XML 26 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
OPERATING ACTIVITIES      
Net (loss) income $ (204,516) $ 83,072 $ 87,362
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 45,448 43,176 40,389
Asset impairments 255,116 0 0
Interest accretion of convertible notes discount 11,535 10,662 9,854
Financing costs amortization 1,290 1,392 1,306
Employee share-based compensation expense 11,325 9,420 9,989
Unrealized foreign currency transaction loss (gain) 78 (1,606) (3,388)
Deferred income tax benefit (24,403) (248) (1,607)
Other non-cash operating activities 737 (170) 4,514
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable 7,195 43,079 (69,287)
Inventory 11,988 (8,150) (12,679)
Unbilled contract revenues and other assets 12,250 (51,467) (10,875)
Accounts payable and other liabilities (16,293) 11,660 (5,259)
Deferred income taxes (51) (3,690) (793)
Customer advances and billings in excess of contract revenue (9,710) (18,413) 10,137
Net Cash Provided By Operating Activities 101,989 118,717 59,663
INVESTING ACTIVITIES      
Capital expenditures (47,039) (62,135) (72,585)
Payments for China land use rights (11,043) 0 0
Government grants 8,650 0 0
Proceeds from sale of assets 425 1,593 569
Acquisition of businesses, net of cash acquired (24,517) (11,943) (2,965)
Net Cash Used In Investing Activities (73,524) (72,485) (74,981)
FINANCING ACTIVITIES      
Borrowings on revolving credit facilities 68,827 88,819 214,623
Repayments on revolving credit facilities (67,196) (87,162) (211,403)
Payments on long-term debt 0 (68,437) (3,750)
Payments for debt issuance costs 0 (1,321) 0
Payment of contingent consideration (611) (741) 0
Proceeds from exercise of stock options 486 763 5,335
Excess Tax Deficiency from share-based Compensation, Financing Activities (890)    
Excess tax (deficiency) benefit from exercise of stock options   1,859 6,673
Common stock repurchases (948) (3,367) (2,002)
Dividend distribution to noncontrolling interest (120) (1,206) (1,369)
Proceeds from (Payments for) Other Financing Activities (156) 0 0
Net Cash (Used In) Provided By Financing Activities (608) (70,793) 8,107
Effect of exchange rate changes on cash (7,805) (9,128) 3,058
Net increase (decrease) in cash and cash equivalents 20,052 (33,689) (4,153)
Cash and cash equivalents at beginning of period 103,656 137,345 141,498
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 123,708 $ 103,656 $ 137,345